Profession Notes

Tools of the Trade As knowledge advances regarding deadly diseases and subsequent treatments, many scientists are relying on the tools and techniques being developed by biotechnology companies to achieve research goals. One genomic information company, Incyte Genomics of Palo Alto, Calif., recently launched Incyte.com, a genomics Web site with proprietary human gene as well as public domain sequence information. The company is focused on the discovery and analysis of genes as they are expressed

Written byKate Devine
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

--Kate Devine

As a means of addressing research integrity, an increasing concern in all academic disciplines, the federal government recently announced a research integrity conference and grant program aimed at fostering empirical research on factors that positively or negatively affect this integrity. According to the Department of Health and Human Services Office of Research Integrity (ORI), little empirical evidence exists to guide government, research institutions, scientists, and professional societies in policy development and decision making regarding integrity in research. Lack of research also has prevented development of an information base for policies and programs to ensure integrity in research and to assess the impact on public health when good research practices are not followed. The first Research Conference on Research Integrity, sponsored by the ORI and co-sponsored by the American Association for the Advancement of Science, the Association of American Medical Colleges, the National Science Foundation, and the National Institutes ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies